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The aims of the present study were to assess regional differences of ET-1, ANP, and IGF-1 gene expression in the left ventricle during early and late postinfarction remodeling in hearts with small and large infarctions; to determine whether mechanical loading was associated with changes in expression; and to identify which hemodynamic measurement best predicted these changes. Study design. The animals were randomized to either ligation of the left coronary artery or sham operation. Animals with large infarctions were euthanized on one of the following days: day 3 (n ϭ 3), 5 (n ϭ 3), 7 (n ϭ 7), and 42 (n ϭ 5); animals with small infarctions were euthanized on one of the following days: day 7 (n ϭ 6) and 42 (n ϭ 7); and sham-operated animals were euthanized on one of the following days: day 7 (n ϭ 6) and 42 (n ϭ 7) after surgery. Left ventricular (LV) pressure measurement, echocardiography, infarct size assessment, and cardiac tissue isolation were performed on all animals. Cardiomyocytes were isolated from a separate set of animals with large infarctions (n ϭ 6) and from sham-operated animals (n ϭ 6) 7 and 42 days after surgery.
MATERIALS AND METHODS

Animals
Myocardial infarction. Animals were anesthetized with 3% halothane (Fluothane, Zeneca; Macclesfield, UK) in a 70% O 2-30% N2O mixture and intubated and ventilated on a volume-controlled ventilator (model 655, Harvard Apparatus; Edenbridge, UK) with 1% halothane in a 70% O2-30% N2O mixture. After a left thoracotomy was performed, the pericardium was opened, and the left coronary artery was ligated with a polyester suture (Ethibond 6-0, needle RB-2, Ethicon; Norderstedt, Germany). Sham-operated animals were subjected to the same surgical procedures except the coronary artery ligation. All animals were given 0.05 mg buphrenorfin (Temgesic, 0.3 mg/ml, Reckitt and Coleman; Hull, UK) subcutaneously immediately and 10 h after surgery.
Of 69 animals undergoing the infarction procedure, 22 (32%) died within 1 h, 11 (16%) died between 1 and 24 h, and 5 (7%) died more than 24 h after surgery. None of the sham-operated animals died.
LV pressure and echocardiography. Animals were anesthetized as previously described. Measurements were performed in a 0.5% halothane in 70% O 2-30% N2O mixture anesthesia after a 5-min stabilization period. LV pressure was measured with a microtip catheter transducer, model SPR 407 2-F (Millar Instruments; Houston, TX), introduced through the right carotid artery. End-diastolic and peak systolic pressures were calculated as the mean of measurements of five consecutive pressure cycles.
Echocardiography was performed immediately after LV pressure measurements with a GE Vingmed Ultrasound System Five ultrasound scanner and with a 10-MHz linear array probe (GE Vingmed Ultrasound; Horten, Norway). After the rat's chest was carefully shaved, the transducer was placed gently against the chest. Diastolic and systolic LV wall thickness and cavity diameters were calculated as the mean of measurements in five consecutive cardiac cycles in M-mode long-axis recordings following the recommendations of the American Society of Echocardiography (28) .
Infarct size estimation and tissue sampling. After echocardiographic recordings were made, the heart was excised and sectioned into atria and ventricles, including the interventricular septum in the left ventricle. The left ventricle was cut open from base to apex along the middle of the septum, pinned to a plate with endocardium upward, and photographed (Fujicolor Reala, 100 ASA). Infarcted and noninfarcted LV areas were determined from the photo. The excised heart was kept in ice-cold sterile water and handled with autoclaved instruments. The left ventricle was divided into the infarcted area, border zone (0-2 mm outside the infarct), and the remote area (Fig. 1) . Five hematoxylin, erytrosin, and saffron-stained specimens demonstrated adequate detection of border between infarction and border zone with 2-6% infarct tissue in the border zone. All tissue specimens were frozen in liquid nitrogen within 15 min after excision and kept at Ϫ80°C.
Cardiomyocyte isolation. Animals were anesthetized with diethyl ether and heparinized (0.2 ml heparin 1,000 IU/ml iv, Novo Nordisk; Copenhagen, Denmark). To balance day-today variation, one infarcted and one sham-operated heart were isolated each day. Hearts were rapidly removed from the animals and connected to an aortic cannula of a standard Langendorff retrograde perfusion system. Cardiomyocytes were isolated using collagenase as previously described (15) . During the isolation procedure, LV tissue was cut into infarcted, border zone (0-2 mm outside the infarct), and remote areas. Total number of cells and fraction of rod-shaped cells without morphological alterations were counted. Lysis buffer (2 ml per 10 6 cells, Dynal; Oslo, Norway) was added, and the lysate thoroughly mixed before being frozen at Ϫ80°C.
Mean numbers of isolated cells were 3.4 Ϯ 0. 6 10 6 in left ventricles of sham-operated animals, 1.2 Ϯ 0.1 10 6 in border zone, and 0.6 Ϯ 0. 1 10 6 in remote area and were related to the different weights of the sampled tissues. The yields of rodshaped cells were 57 Ϯ 6% in left ventricles of sham-operated animals, 41 Ϯ 4% in border zone, and 41 Ϯ 6% in remote area.
mRNA isolation. Myocardial mRNA was isolated with Dynabeads Oligo(dT) 25 (Dynal) according to manufacturer's instructions. Myocardial tissue (50 mg) was homogenized in 1 ml of cold lysis-binding buffer with an Ultra-Turrax T 25 (Janke & Kunkel IKA-Labortechnik; Staufen, Germany), and the supernatant was mixed with 250 l of Dynabeads Oligo(dT) 25 . Lysate (1 ml) from isolated cardiomyocytes was mixed with 250 l of Dynabeads Oligo(dT)25. After five washing procedures, the mRNA was eluted in 25 l of elution buffer per 50 mg of tissue or per 1 ϫ 10 6 cardiomyocytes. Eluates were frozen at Ϫ80°C. Competitive RT-PCR. Competitive RT-PCR was performed in a Perkin-Elmer GeneAmp 2400 PCR system using rTth DNA polymerase (Perkin-Elmer/Roche Molecular Systems; Bronchburg, NJ) according to manufacturer's instructions. Reverse transcription for ET-1, ANP, and IGF-1 was performed at 50°C for 5 min and 61°C for 40 min followed by 3 min denaturation at 95°C.
ET-1 PCR amplification was performed for 27 cycles at 94°C for 20 s, 55°C for 15 s, and 72°C for 30 s. For each sample of ET-1 mRNA, RT-PCR was performed in three tubes, each with the same amount of sample mRNA together with 0.05, 0.15, and 0.45 attomol of DNA competitor, respectively. The DNA competitor consisted of the 313-bp endothelin gene sequence targeted by the PCR primers listed below, including a 149-bp coding sequence and an intercalated 164-bp intron. The DNA competitor was cloned into a pCR2 vector and transformed in an INV␣F' Escherichia coli strain using Original TA Cloning Kit (Invitrogen; Groningen, Netherlands). Prepro-ET-1-specific sense and antisense primer sequences were 5Ј-GTGCTCACCAAAAAGACAAG-3Ј (bp 519-538) and 5Ј-CAGCTGCTGATAGATACACTTC-3Ј (bp 667-646). Sequencing of RT-PCR products confirmed amplification of the predicted templates.
ANP PCR amplification was performed for 27 cycles at 94°C for 20 s, 55°C for 15 s, and 72°C for 30 s. To quantify one sample of ANP mRNA, RT-PCR was performed in three tubes, each with the same amount of mRNA together with 0.11, 0.44, and 1.76 fmol of DNA competitor, respectively. The DNA competitor consisted of a 472-bp fragment, including the primers listed below and an intercalated sequenced DNA fragment from human mitochondrial NADH. The sequences of the ANP-specific sense and antisense primers were 5Ј-GGGCTCCTTCTCCATCACC-3Ј and 5Ј-CTCCAATC-CTGTCAATCCTACC-3Ј.
IGF-1 PCR amplification was performed for 30 cycles at 94°C for 30 s, 54°C for 30 s, and 72°C for 30 s. A slightly different RT-PCR protocol was used for IGF-1 than for ET-1 and ANP. Competitive RT-PCR of IGF-1 mRNA was performed in one tube with 1 l of mRNA eluate from sample and 13.6 attomol of DNA competitor. For each gel, a standard curve was made by analyzing samples with six known amounts of IGF-1 cDNA fragments (1.29, 2.57, 12.85, 25.7, 128.5, and 257 attomol) and 13.6 attomol of DNA competitor. The DNA competitor was made by cloning of a 500-bp fragment amplified with the specific IGF-1 primers from rat genomic DNA. The IGF-1 cDNA fragments for the standard curve was made by cloning of cDNA amplified with the specific IGF-1 sense and antisense primers. Sequences of the IGF-1-specific sense and antisense primers were 5Ј-ATTGT-GGATGAGTGTTGCTTC-3Ј and 5Ј-ATTGATATTTGGCAG-GTGTTCC-3Ј. All DNA competitors and cDNA for IGF-1 standard curves were quantified by spectrophotometry at 260 nm (GeneQuant, Pharmacia; Uppsala, Sweden).
Quantification of the PCR fragments and mRNA. PCR products were separated by electrophoresis (80 V in 110 min for ET-1, 80 V in 130 min for ANP, and 80 V in 90 min for IGF-1) on a 2.5% NuSieve 3:1 agarose gel (FMC BioProducts; Rockland, ME) stained with 20 g of ethidium bromide per 100 ml of gel. Fluorescence was detected with a chargecoupled device camera (model WBP 312, Panasonic, CCTV Camera; Osaka, Japan) and digitally analyzed (Gel-Pro Analyzer Version 3.0, Media Cybernetics; Silver Spring, MD). For ET-1 and ANP, ethidium bromide fluorescence of the competitor was multiplied by the ratio of sample cDNA base pair to competitor DNA base pair, thereby accounting for the difference in fluorescence caused by the difference in length between the sample cDNA fragment and the competitor. For ET-1 and ANP, the logarithm of the sample-to-competitor fluorescence ratio was plotted against the logarithm of the known amount of competitor added to each tube, resulting in a linear relationship. The line of best fit was calculated using least sum of squares method. Sample mRNA content was calculated by setting the logarithm of sample-to-competitor fluorescence ratio to 0 in the linear equation. For IGF-1, a standard curve was calculated for each set of PCR by plotting the logarithm of the sample to standard fluorescence ratio against the six amounts of IGF-1 cDNA added to tubes. IGF-1 mRNA content in each sample was assessed by fitting the logarithm of the sample-to-competitor fluorescence ratio into the standard curve equation. To assess intraassay variation, six samples from the same mRNA isolation were analyzed in parallel. Reproducibility was good for ET-1 and IGF-1 (coefficients of variation 0.11 and 0.19, respectively). ANP reproducibility was good at high levels (coefficient of variation 0.18). For ANP levels in controls, which were near the detection limit, the coefficient of variation was 0.38, implying that the concentrations in normal hearts may not be as accurately detected as in failing hearts. However, these inaccuracies would not affect comparisons with failing hearts because those concentrations were 10-to 45-fold higher. Accuracy of the mRNA analysis for ET-1, ANF, and IGF-1 is shown in Fig. 2 .
Wall stress estimation. Wall stress in the remote area was estimated using an equation by Falsetti and Sandler (8, 32) : Meridional wall stress m ϭ PRi/2h(1 ϩ h/2Ri), where P is LV pressure, Ri is LV inner radius, and h is wall thickness. This expression gives a representative estimate of wall stress in the remote area provided that wall thickness is fairly constant, the tissue is fairly homogenous within the area analyzed, and there is axisymmetry of the radius. Analysis of long-and short-axis recordings confirmed a more spherical LV shape in failing hearts than in control hearts. The ratio of diastolic anteroposterior versus laterolateral diameter was 1.15 Ϯ 0.13 (means Ϯ SD) for control hearts and 1.03 Ϯ 0.05 and 1.03 Ϯ 0.06 in hearts with large infarctions after 7 and 42 days, respectively. Corresponding results for long-axis (5) . The reported association of gene expression with hemodynamic measurements was analyzed by forward stepwise multiple linear regression (1). Similar results were obtained using ranks (data not shown). P Ͻ 0.05 was considered statistically significant.
RESULTS
Gene expression. Myocardial infarction markedly induced LV ET-1 expression with increased ET-1 mRNA in all regions of the infarcted left ventricle at all examined time points after small and large infarctions (Fig.  3, A and D) . Expression was time and region dependent with a marked peak in all regions at day 7, with ET-1 mRNA 19 times control in the infarct, 10 times control in the border zone, and 4 times control in the remote area after large infarctions. The regional differences were reproduced in cardiomyocytes isolated 7 and 42 days after large myocardial infarctions, as shown in Fig. 3G .
Myocardial expression of ANP increased in a different pattern (Fig. 3, B and E) . ANP mRNA was strongly induced in all regions of the infarcted left ventricle with highest expression in the border zone and remote area. After large infarctions, there was no distinctive peak but a sustained high mRNA level at days 7 and 42 in the border zone (37 and 47 times control) and remote area (39 and 38 times control). In isolated cardiomyocytes, the high level of ANP mRNA was reproduced (Fig. 3H) . However, regional differences changed during remodeling. After 7 days ANP expression was highest in cardiomyocytes from the border zone, whereas after 42 days it was highest in cardiomyocytes from the remote area.
IGF-1 gene expression was transient, with high levels in the early phase and low levels in the late phase after infarction. IGF-1 mRNA levels were highest in all regions at 7 days (Fig. 3 , C and F) with 14 times control in the infarct, 8 times control in the border zone, and 3 times control in the remote area after large infarctions. After 42 days, IGF-1 expression was normalized in the remote area but still moderately upregulated in the border zone and infarct. Expression in isolated cardiomyocytes after infarction differed from that in myocardial tissue (Fig. 3I) , with considerably lower IGF-1 mRNA levels compared with control. After 7 days there was only a moderate upregulation in the remote area and border zone (1.4 and 2.4 times control), whereas there was no significant upregulation after 42 days.
Comparison of gene expression after small and large infarctions revealed different results for ET-1, ANP, and IGF-1. Large and small infarctions induced similar patterns of IGF-1 expression in the left ventricle. However, large infarctions induced higher ET-1 and ANP expression in the remote area than did small infarctions.
Echocardiography, LV pressure, weights, and infarct size. As shown in Table 1 , infarct size was a strong predictor for heart failure and remodeling. Large myocardial infarctions lead to a progressive eccentric hypertrophy of the left ventricle with 70% increase in diastolic and 151% increase in systolic LV diameter at day 42. After small infarctions, the corresponding dilation was 35% and 86%, without statistically significant progression from day 7 to day 42. The noninfarcted cardiac chambers hypertrophied markedly after large infarctions (Table 2) . Left atrial hypertrophy was observed 3 days after infarction and increased to 240% after 42 days, whereas right atria and ventricles hypertrophied with 250% and 123% at 40 days, respectively. Mechanical load increased progressively after large infarctions, with a ninefold increase in diastolic and a threefold increase in systolic posterior wall stress. Infarct size, body weights, and chamber weights are presented in Table 2 .
Association of gene expression and mechanical forces. End-diastolic posterior wall stress was the best hemodynamic predictor of myocardial ET-1 and ANP expression in the remote area both at days 7 and 42 (Fig. 4) . When it was included in a stepwise multiple linear regression model together with systolic wall stress, peak systolic pressure, LV end-diastolic pressure, diastolic LV diameter, systolic LV diameter, and posterior wall thickening, none of the other variables added significantly to the linear regression model. End-diastolic wall stress did not correlate with ET-1 and ANP expression in the border zone or infarcted area except for ANP in the border zone at day 42 (r ϭ 0.77, P ϭ 0.003). For myocardial IGF-1 expression, there was no statistically significant correlation with the hemodynamic parameters analyzed.
DISCUSSION
This study is the first to present that the cardioactive peptides ET-1, ANP, and IGF-1 are expressed in dis- tinctly different patterns after myocardial infarction. Implications of the detected differences in regional and cellular distribution, temporal changes, and relation to mechanical forces are discussed below.
ET-1 gene expression. In the present study, we confirmed previous observations by immunohistochemistry and in situ hybridization, demonstrating highest expression in granulation tissue in infarcted area and in the adjacent myocardium (23, 38) . Whether cardiomyocytes contribute to increased ET-1 expression after myocardial infarction has been uncertain. We found a similar pattern of regional ET-1 expression in isolated cardiomyocytes and myocardium, demonstrating that cardiomyocytes contribute to the increased ET-1 expression in the viable myocardium postinfarction and to the higher level in the border zone than in the remote area. After 7 days, border zone ET-1 expression increased 4-fold in isolated cardiomyocytes and 10-fold in myocardium, suggesting higher expression in nonmyocytes than in cardiomyocytes. This might be due to induction of ET-1 expression in nonmyocytes and higher content of nonmyocytes in the border zone.
Examination of hematoxylin, erytrosin, and saffronstained samples revealed scarce islets of scar tissue (2-6%) in the border zone adjacent to the infarct. Immunohistochemistry has suggested high levels of ET-1 in macrophages, fibroblasts, endothelial cells, and remaining cardiomyocytes, and in situ hybridization indicates a high level of mRNA in granulation tissue (23, 38) .
Peak ET-1 expression concurs with maximum myocardial infiltration of chronic inflammatory cells (9, 25) and peak plasma and myocardial levels of tumor necrosis factor-␣ (TNF-␣), interleukin-1 (IL-1), and transforming growth factor-␤ (TGF-␤) (25, 42) , which are known inducers of ET-1 expression, and suggest a role of ET-1 in myocardial inflammation and repair during early remodeling. This is supported by the detrimental effects of ET-1 antagonism early postinfarction with impaired scar healing and increased infarct thinning (22) .
Stretch induces ET-1 in isolated cardiomyocytes (41) and cultured endothelial cells (40) , but the role of mechanical load on myocardial ET-1 expression in vivo has been unclear. The present study is the first to document a significant correlation between diastolic wall stress and ET-1 expression in the remote area of the infarcted heart. The results suggest that stretching of the myocardium during diastole contributes significantly to the induction of ET-1 in both acute and chronic postinfarction heart failure.
ANP gene expression. The persistent high levels and regional distribution of ANP expression quantified in the present study agree with results obtained by immunohistochemistry in humans and rats, demonstrating high levels in areas adjacent to the infarct, in the subendocardium of the infarct, and in viable cardiomyocytes within the infarct (17, 36) As expected, but not previously reported, ANP expression correlated strongly with end-diastolic wall stress in the remote area. This observation supports the current opinion that stretch is the most important inducer of myocardial expression in vivo of ANP and other proteins such as ␤-cardiac myosin heavy chain (3, 33) . Remote area and border zone ANP levels did not increase significantly from day 7 to day 42, despite the 71% increase in diastolic wall stress. This might be because the ANP response to mechanical load has already reached a maximum at day 7, or because other stimuli inducing ANP has declined, such as paracrine effects of ET-1 and other local mediators.
IGF-1 gene expression. Which types of cells are the main contributors to myocardial IGF-1 mRNA has been unsettled. Seven days after infarction, IGF-1 expression in isolated cardiomyocytes increased 1.4-fold in the remote area and 2.4-fold in the border zone, which is comparable to the results of Cheng and coworkers (4). However, in myocardial tissue, IGF-1 expression increased threefold in the remote area and eightfold in the border zone, suggesting that nonmyocytes are the main source of myocardial IGF-1 mRNA postinfarction. This is supported by the results of Dean and co-workers (6), who found IGF-1 mRNA predominantly in the infarct and the peri-infarct area, located in blood vessels, endocardium, and cellular infiltrates, with little expression in the hypertrophied remote area. The regulatory mechanisms of IGF-1 expression in cardiomyocytes are largely unknown. In endothelial cells, IGF-1 is downregulated by hypoxia (39) and upregulated by IL-1 (12), whereas expression is stimulated by stretch in isolated vascular smooth muscle cells (34) and skeletal muscle cells (13) . In the present study, IGF-1 expression was normal in the remote area despite a ninefold increase in diastolic wall stress, and there was no correlation between myocardial IGF-1 mRNA and mechanical load. These findings, which have not been previously reported, suggest that stretch alone is not a major stimulus for myocardial IGF-1 expression after myocardial infarction in rats.
The pattern of IGF-1 expression found in the present study is very similar to those of TNF-␣, IL-1␤, IL-6, and TGF-␤ found in cardiac nonmyocytes in an identical model (42) , suggesting similar regulatory mechanisms for IGF-1 and cytokines participating in the inflammatory processes. A role of IGF-1 in inflammation and repair agrees well with the transient increase in myocardial IGF-1 expression, the higher expression in cardiac nonmyocytes, and the lack of association to mechanical load after myocardial infarction.
Patterns of gene expression. The differential patterns of myocardial ET-1, ANP, and IGF-1 expression demonstrated in the present study reveal differing regulatory responses to mechanical forces and chemical stimuli. ANP expression was closest related to mechanical forces, and IGF-1 expression increased simultaneously with the highest chemical influences, whereas ET-1 expression was associated with both stimuli.
The results also confirm distinct differences in gene expression between the border zone and remote area. These differences might be caused by regional differences in wall stress. Using a finite element model, Bogen et al. (2) estimated 3.7 times higher systolic wall stress in the border zone than in the remote area of the acute infarcted canine left ventricle. However, border zone wall stress was reduced as infarct stiffness increased with time, suggesting time-dependent influences of mechanical load on border zone gene expression. Gene expression of isolated cardiomyocytes support this assumption, because ANP expression was highest in the border zone after 7 days but highest in the remote area after 42 days.
The observed patterns of gene expression agree well with the concepts of an early and a late phase in postinfarction remodeling. The general high expression of all genes after 7 days is consistent with high levels of several inducing factors, including mechanical forces, hormones, and paracrine factors induced by inflammation and repair in infarcted areas. After 42 days, gene expression had decreased in all regions except for ANP in hearts with large infarctions, consistent with abating inflammation but sustained high mechanical load. There was, however, still high expression of ET-1, ANP, and IGF-1 in the infarcted area and border zone after 42 days. The infarct and adjacent myocardium might therefore exert paracrine and humoral activity even in chronic postinfarction heart failure.
Hemodynamic measurements. The study results demonstrate a consistent association between size of myocardial infarction and degree of cardiac remodeling, reduced cardiac function, and increased LV mechanical load. Most prominent was the marked increase in end-diastolic wall stress after large infarctions. Diastolic wall stress estimates the diastolic stretching forces working per area of myocardium. Consequently, in postinfarction failure increased stretching forces act on the noninfarcted myocardium during diastole when contracting myofibrils do not protect the tissue. The correlation between diastolic wall stress and gene expression of ET-1 and ANP suggests that diastolic myocardial stretch is an important stimulus to postinfarction remodeling.
In conclusion, the present study documents that ET-1, ANP, and IGF-1 are expressed in markedly different patterns in the infarcted heart in relation to time, functional regions, cellular distribution, and me-chanical load. Diastolic wall stress is associated with a substantial increase in ANP expression and a moderate increase in ET-1 expression in the viable myocardium during acute and chronic postinfarction failure, suggesting that stretching in diastole induces these genes in vivo.
